Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;25(12):3292-3303.
doi: 10.1038/s41380-019-0559-1. Epub 2019 Nov 20.

A major role for common genetic variation in anxiety disorders

Affiliations

A major role for common genetic variation in anxiety disorders

Kirstin L Purves et al. Mol Psychiatry. 2020 Dec.

Abstract

Anxiety disorders are common, complex psychiatric disorders with twin heritabilities of 30-60%. We conducted a genome-wide association study of Lifetime Anxiety Disorder (ncase = 25 453, ncontrol = 58 113) and an additional analysis of Current Anxiety Symptoms (ncase = 19 012, ncontrol = 58 113). The liability scale common variant heritability estimate for Lifetime Anxiety Disorder was 26%, and for Current Anxiety Symptoms was 31%. Five novel genome-wide significant loci were identified including an intergenic region on chromosome 9 that has previously been associated with neuroticism, and a locus overlapping the BDNF receptor gene, NTRK2. Anxiety showed significant positive genetic correlations with depression and insomnia as well as coronary artery disease, mirroring findings from epidemiological studies. We conclude that common genetic variation accounts for a substantive proportion of the genetic architecture underlying anxiety.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Manhattan and Q-Q plots for UK Biobank anxiety analyses
Manhattan and Q-Q plots of p-values of Single Nucleotide Polymorphisms (SNP) based association analyses of anxiety in the UK Biobank. In the Manhattan plots, the threshold for genome-wide significance (p < 5×10−08) Is indicated by the red line, while the blue line indicates the threshold for suggestive significance (p < 1×10−5). Top panel showing results for our core Lifetime Anxiety Disorder analysis. Bottom panel showing results for the Current Anxiety Symptoms analysis.
Figure 2.
Figure 2.. Genetic correlations between UK Biobank Lifetime Anxiety Disorder and significantly associated external traits
Figure showing genetic correlations (rG) between UK Biobank “Lifetime Anxiety Disorder” and external phenotypes generated from LDhub. Only traits where correlation exceeded Bonferroni corrected threshold of p < 0.0002 shown here. Depression and neuroticism were not included in this analysis as they have been included as replication samples in subsequent analyses. See supplementary table 7 for rG with the latest publically available neuroticism and MDD GWAS samples including UK Biobank. Asterisks (*) Indicates source study sample wholly or partially included UK Biobank participants. Correlations ordered first by rG within category. Bars show standard error of the estimate.
Figure 3.
Figure 3.. Gene Manhattan plot with top significant gene per chromosome
Manhattan plots of p-values of gene-wise association analyses of “Lifetime Anxiety Disorder” in the UK Biobank. In the Manhattan plots, the threshold for gene-wide significance (p < 3×10–06) Is indicated by the red line, while the blue line indicates the threshold for suggestive significance (p < 1×10–5)
Figure 4.
Figure 4.. Manhattan and Q-Q plots for meta-analysis of all Lifetime Anxiety Disorder samples
Manhattan and Q-Q plots of p-values of Single Nucleotide Polymorphisms (SNP) based association analyses of combined sample meta-analysis across three Lifetime Anxiety Disorder cohorts (UK Biobank, ANGST and iPSYCH). In the Manhattan plots, the threshold for genome-wide significance (p < 5×10–08) Is indicated by the red line, while the blue line indicates the threshold for suggestive significance (p < 1×10–5)

Similar articles

Cited by

References

    1. Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J et al. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc 2009; 18: 23–33. - PMC - PubMed
    1. Wittchen H-U, Jacobi F. Size and burden of mental disorders in Europe--a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005; 15: 357–376. - PubMed
    1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1789–1858. - PMC - PubMed
    1. Polderman TJC, Benyamin B, de Leeuw CA, Sullivan PF, van Bochoven A, Visscher PM et al. Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat Genet 2015; 47: 702–709. - PubMed
    1. Craske MG, Stein MB, Eley TC, Milad MR, Holmes A, Rapee RM et al. Anxiety disorders. Nat Rev Dis Primers 2017; 3: 17024. - PMC - PubMed

Publication types

MeSH terms